These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7190409)
21. Effect of Venoruton on the factor XIII activity in rat plasma. Grochal M; Sempińska-Edelberg E; Plewiński J Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007 [TBL] [Abstract][Full Text] [Related]
22. Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man. Balant LP; Wermeille M; Griffiths LA Q Rev Drug Metab Drug Interact; 1984; 5(1):1-24. PubMed ID: 6397783 [No Abstract] [Full Text] [Related]
24. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs. Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865 [TBL] [Abstract][Full Text] [Related]
25. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease. Bielawiec M; Kiersnowska-Rogowska B; Dabrowski S; Lukjan H Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):103-8. PubMed ID: 88383 [TBL] [Abstract][Full Text] [Related]
26. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel]. Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532 [TBL] [Abstract][Full Text] [Related]
27. Effect of o-(beta-hydroxyethyl)-rutosides on the microrheology of human blood under defined flow conditions. Schmid-Schönbein H; Volger E; Weiss J; Brandhuber M Vasa; 1975; 4(3):263-70. PubMed ID: 1179829 [No Abstract] [Full Text] [Related]
28. Determination of individual hydroxyethyl rutosides in various animal body fluids by thin-layer chromatography and scanning densitometry. Hackett AM; Niebes P; Griffiths LA J Chromatogr; 1978 Feb; 148(2):469-75. PubMed ID: 621266 [TBL] [Abstract][Full Text] [Related]
29. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study. Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162 [TBL] [Abstract][Full Text] [Related]
30. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry. Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163 [TBL] [Abstract][Full Text] [Related]
31. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease. Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S Bibl Anat; 1979; (18):378-81. PubMed ID: 496871 [No Abstract] [Full Text] [Related]
32. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals. Bergqvist D; Svensjö E; Arfors KE Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118 [TBL] [Abstract][Full Text] [Related]
33. The effect of O-(beta-hydroxyethyl)-rutosides on central haemodynamics during and after aortocoronary bypass surgery. Ekeström S; Sonnenfeld T; Lund F Scand J Thorac Cardiovasc Surg; 1984; 18(3):255-8. PubMed ID: 6335602 [TBL] [Abstract][Full Text] [Related]
35. Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration. Rehn D; Brunnauer H; Diebschlag W; Lehmacher W Arzneimittelforschung; 1996 May; 46(5):488-92. PubMed ID: 8737632 [TBL] [Abstract][Full Text] [Related]
36. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease. Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503 [No Abstract] [Full Text] [Related]
37. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers. Mann RJ Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736 [No Abstract] [Full Text] [Related]
38. Histochemical alterations in the adult rat brain after X-ray irradiation: effects of O-(beta-hydroxyethyl)-rutosides. Lehmann FM; Lierse W; Thiel HJ Acta Anat (Basel); 1989; 135(3):275-80. PubMed ID: 2528882 [TBL] [Abstract][Full Text] [Related]
39. Identification and quantification of O-(beta-hydroxyethyl)-rutosides by mass spectrometry selected ion monitoring. Kuhnz W; Rembold H Biomed Mass Spectrom; 1980 Jun; 7(6):269-72. PubMed ID: 7426692 [TBL] [Abstract][Full Text] [Related]
40. [LDH- and MDH-isoenzymes in the costo-chondral junction in experimental lathyrismus and under additional medication with 6-methyl-prednisolone and O-(beta-hydroxyethyl)-rutosides]. Hartmann F; Trebe D Z Rheumatol; 1975; 34(9-10):314-28. PubMed ID: 1202842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]